Rossana Scrivo

Dr. Rossana Scrivo

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RSRossana Scrivo
Rossana Scrivo
LMLaura Massaro
Laura Massaro
CBCristiana Barbati
Cristiana Barbati
MVMarta Vomero
Marta Vomero
FCFulvia Ceccarelli
Fulvia Ceccarelli
GVGuido Valesini
Guido Valesini
We aimed at investigating whether the frequency and function of T helper 17 (Th17) and regulatory T cells (Treg) are affected by a restriction of dietary sodium intake in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). We enrolled RA and SLE patients not receiving drugs known to increase urinary sodium excretion. Patients underwent a dietary regimen starting with a restricted daily sodium intake followed by a normal-sodium daily intake. The timepoints were identified at baseline (T0), after 3 weeks of low-sodium dietary regimen (T3), after 2 weeks of normal-sodium dietary regimen (T5). On these visits, we measured the 24-hour urinary sodium excretion, the frequency and function of Th17 and Treg cells in the peripheral blood, the serum levels of cytokines. Analysis of urinary sodium excretion confirmed adherence to the dietary regimen. In RA patients, a trend toward a reduction in the frequencies of Th17 cells over the low-sodium dietary regimen followed by an increase at T5 was observed, while Treg cells exhibited the opposite trend. SLE patients showed a progressive reduction in the percentage of Th17 cells that reached a significance at T5 compared to T0 (p = 0.01) and an increase in the percentage of Treg cells following the low-sodium dietary regimen at both T1 and T3 compared to T0 (p = 0.04 and p = 0.02, respectively). No significant apoptosis or proliferation modulation was found. In RA patients, we found a reduction at T5 compared to T0 in serum levels of both TGFβ (p = 0.0016) and IL-9 (p = 0.0007); serum IL-9 levels were also reduced in SLE patients at T5 with respect to T0 (p = 0.03). This is the first study investigating the effects of dietary sodium intake on adaptive immunity. Based on the results, we hypothesize that a restricted sodium dietary intake may dampen the inflammatory response in RA and SLE patients.

1 July 2021 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
RPRoberta Priori
Roberta Priori
GPGreta Pellegrino
Greta Pellegrino
SCSerena Colafrancesco
Serena Colafrancesco
CAcristiano alessandri
cristiano alessandri
FCFulvia Ceccarelli
Fulvia Ceccarelli
FCFabrizio Conti
Fabrizio Conti

18 April 2014 in Current Allergy and Asthma Reports
Verified
Journal Article
Closed access
PDF file
RSRossana Scrivo
Rossana Scrivo
LCLuca Casadei
Luca Casadei
MVMariacristina Valerio
Mariacristina Valerio
RPRoberta Priori
Roberta Priori
GVGuido Valesini
Guido Valesini
CMCesare Manetti
Cesare Manetti

14 October 2019 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
AOAna‐Maria Orbai
Ana‐Maria Orbai
JPJamie Perin
Jamie Perin
CGClémence Gorlier
Clémence Gorlier
LCLaura C. Coates
Laura C. Coates
UKUta Kiltz
Uta Kiltz
LGLaure Gossec
Laure Gossec

2 September 2014 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
RSRossana Scrivo
Rossana Scrivo
PCP. Conigliaro
P. Conigliaro
VRValeria Riccieri
Valeria Riccieri
MFM. Di Franco
M. Di Franco
CAcristiano alessandri
cristiano alessandri
GVG. Valesini
G. Valesini
Evidence exists that interleukin (IL)‐10 family cytokines may be involved in the pathogenesis of rheumatoid arthritis (RA). We sought to determine whether or not these cytokines are involved in psoriatic arthritis (PsA). We conducted a prospective study on patients with PsA, RA and osteoarthritis (OA); healthy controls (HC) were also included. We analysed IL‐20, IL‐24 and IL‐19 serum and synovial fluid (SF) levels and change of serum levels following treatment with biological agents. IL‐20 serum levels were increased in PsA and RA compared with OA patients and HC and with matched SF levels. IL‐24 serum levels in PsA, RA and OA patients were higher than those in HC and also with respect to matched SF in PsA. IL‐19 serum levels were higher in HC and OA compared with PsA and RA patients; IL‐19 SF levels were higher in PsA and RA compared with OA patients, and in PsA compared with RA patients. PsA and RA patients showed a reduction of IL‐19 serum levels after biological treatment. Therefore, IL‐19 seems to be involved mainly in the joint inflammation, whereas IL‐20 and IL‐24 appear to participate mainly in the systemic responses. These findings may further the comprehension of the contribution of these cytokines to the inflammatory response involved in chronic arthritis, as well as to the development of novel therapeutic strategies.

5 August 2012 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
RSRossana Scrivo
Rossana Scrivo
ISIlaria Sauzullo
Ilaria Sauzullo
FMFabio Mengoni
Fabio Mengoni
GIGiancarlo Iaiani
Giancarlo Iaiani
AVAnna Rita Vestri
Anna Rita Vestri
GVGuido Valesini
Guido Valesini